Reproductive endocrinology: Hormone therapy to treat menopause--breaking a taboo.

作者信息

Davis Susan R

机构信息

Women's Health Program, School of Public Health and Preventive Medicine, Monash University, Level 6, 99 Commercial Road, Melbourne, VIC 3004, Australia.

出版信息

Nat Rev Endocrinol. 2014 Jan;10(1):6-8. doi: 10.1038/nrendo.2013.219. Epub 2013 Oct 29.

DOI:10.1038/nrendo.2013.219

PMID:24165999

Abstract

摘要

相似文献

Reproductive endocrinology: Hormone therapy to treat menopause--breaking a taboo.

Nat Rev Endocrinol. 2014 Jan;10(1):6-8. doi: 10.1038/nrendo.2013.219. Epub 2013 Oct 29.

Hormone therapy use and outcomes in the Women's Health Initiative trials.

JAMA. 2014;311(4):417. doi: 10.1001/jama.2013.285154.

Menopausal hormone therapy has risks and benefits during the intervention and poststopping phase.

Evid Based Med. 2014 Jun;19(3):105. doi: 10.1136/eb-2013-101656. Epub 2014 Feb 3.

Hormone therapy use and outcomes in the Women's Health Initiative trials--reply.

JAMA. 2014;311(4):417-8. doi: 10.1001/jama.2013.285163.

The Women's Health Initiative--a victory for women and their health.

JAMA. 2013 Oct 2;310(13):1349-50. doi: 10.1001/jama.2013.278042.

Menopausal hormone therapy and prevention of chronic diseases: IMS members react to the recent JAMA paper.

Climacteric. 2014 Feb;17(1):99-101.

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

JAMA. 2013 Oct 2;310(13):1353-68. doi: 10.1001/jama.2013.278040.

Postmenopausal hormone therapy offers no protection against heart attacks.

Ginecol Obstet Mex. 2002 Aug;70:404-5.

The case for hormone replacement: new studies that should inform the debate.

Cleve Clin J Med. 2002 Sep;69(9):670, 672-3, 677-8. doi: 10.3949/ccjm.69.9.670.

Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study.

Ginecol Obstet Mex. 2002 Aug;70:411-2.

本文引用的文献

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

JAMA. 2013 Oct 2;310(13):1353-68. doi: 10.1001/jama.2013.278040.

Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.

Climacteric. 2013 Jun;16(3):316-37. doi: 10.3109/13697137.2013.795683.

Where are we 10 years after the Women's Health Initiative?

J Clin Endocrinol Metab. 2013 May;98(5):1771-80. doi: 10.1210/jc.2012-4070. Epub 2013 Mar 14.

Understanding weight gain at menopause.

Climacteric. 2012 Oct;15(5):419-29. doi: 10.3109/13697137.2012.707385.

Using longitudinal profiles to characterize women's symptoms through midlife: results from a large prospective study.

Menopause. 2012 May;19(5):549-55. doi: 10.1097/gme.0b013e3182358d7c.

The impact of menopausal symptoms on work ability.

Menopause. 2012 Mar;19(3):278-82. doi: 10.1097/gme.0b013e31822ddc97.

Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.

Drugs. 2011 Sep 10;71(13):1649-57. doi: 10.2165/11592820-000000000-00000.

Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study.

BMJ. 2007 Dec 1;335(7630):1134. doi: 10.1136/bmj.39367.495995.AE. Epub 2007 Nov 6.

A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer.

Nutr Cancer. 2002;44(2):127-38. doi: 10.1207/S15327914NC4402_02.

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验